• 6821 Citations
  • 46 Scopus h-Index
1992 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kah-Whye Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Galanis, E., Knutson, K. L., Hartmann, L. C., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E., Keeney, G., Shridhar, V., Cliby, W. A., Goode, E. L., Peng, K., Hartmann, L. C. & Lingle, W. L.

National Institutes of Health

10/1/088/31/20

Project: Research project

  • Research Output

    • 6821 Citations
    • 46 Scopus h-Index
    • 121 Article
    • 14 Review article
    • 5 Comment/debate
    • 3 Chapter

    Systemic Safety of a Recombinant AAV8 Vector for Human Cocaine Hydrolase Gene Therapy: A Good Laboratory Practice Preclinical Study in Mice

    Chen, V. P., Gao, Y., Geng, L., Steele, M., Jenks, N., Peng, K. W. & Brimijoin, S., Jan 2020, In : Human gene therapy. 31, 1-2, p. 70-79 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection

    Zhang, L., Suksanpaisan, L., Jiang, H., DeGrado, T. R., Russell, S. J., Zhao, M. & Peng, K. W., Dec 20 2019, In : Molecular Therapy - Oncolytics. 15, p. 178-185 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging

    Vandergaast, R., Khongwichit, S., Jiang, H., DeGrado, T. R., Peng, K-W., Smith, D. R., Russell, S. J. & Suksanpaisan, L., Jan 1 2019, (Accepted/In press) In : Cancer Gene Therapy.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

    Russell, S. J., Babovic-Vuksanovic, D., Bexon, A., Cattaneo, R., Dingli, D., Dispenzieri, A., Deyle, D. R., Federspiel, M. J., Fielding, A., Galanis, E., Lacy, M. Q., Leibovich, B. C., Liu, M. C., Muñoz-Alía, M., Miest, T. C., Molina, J. R., Mueller, S., Okuno, S. H., Packiriswamy, N., Peikert, T. & 6 others, Raffel, C., Van Rhee, F., Ungerechts, G., Young, P. R., Zhou, Y. & Peng, K. W., Jan 1 2019, In : Mayo Clinic proceedings.

    Research output: Contribution to journalReview article

    Open Access
  • 1 Scopus citations

    Oncolytic Viruses: Priming Time for Cancer Immunotherapy

    Russell, L., Peng, K. W., Russell, S. J. & Diaz, R. M., Jan 1 2019, In : BioDrugs.

    Research output: Contribution to journalReview article

    Open Access
  • 6 Scopus citations